1. |
Choti MA. Surgical management of hepatocellular carcinoma:resection and ablation. J Vasc Interv Radiol, 2002, 13(9 Pt 2):S197-S203.
|
2. |
汤钊猷.原发性肝癌.第2版.上海:上海科学技术出版社, 1999:182-185.
|
3. |
黄建钊, 刘江伟, 孙倩, 等.射频消融与手术切除治疗肝癌的疗效比较.广东医学杂志, 2012, 33(13):1991-1993.
|
4. |
Chan AC, Poon RT, Cheung TT, et al. Survival analysis of re-resection versus radiofrequency ablation for intrahepatic recurrence after hepatectomy for hepatocellular carcinoma. World J Surg, 2012, 36(1):151-156.
|
5. |
陈敏华.微创时代肝癌的射频消融治疗.中华消化外科杂志, 2009, 8(1):4-6.
|
6. |
芶欣, 黄建钊, 孙倩, 等.经皮集束射频消融治疗肝血管瘤的近期疗效观察.广东医学, 2011, 32(7):889-890.
|
7. |
Buscarini E, Savoia A, Brambilla G, et al. Radiofrequency thermal ablation of liver tumors. Eur Radiol, 2010, 15(5):884-894.
|
8. |
Truk MJ, Guevara-Patiño JA, Rizzuto GA, et al. Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells. J Exp Med, 2011, 200(6):771-782.
|
9. |
Ormandy LA, Hillemann T, Wedemeyer H, et al. Inreased populations of regulatory T cells in peripheral blood of patients with hepatocellular. Cancer Res, 2005, 65(6):2457-2464.
|
10. |
Jordan MS, Riley MP, von Boehmer H, et al. Anergy and suppression regulate CD4(+) T cell responses to a self peptide. Eur J Immunol, 2000, 30(1):136-144.
|
11. |
Smyth MJ, Thia KY, Street SE, C, et al. Defferential tumor surveillance by NK and NKT cells. J Exp Med, 2000, 191(4):661-668.
|
12. |
Liu Y, Poon RT, Hughes J, et al. Chemokine receptions support infiltration of lymphocyte subpopulations in human hepatocelluar carcinoma. Clin Immunol, 2005, 114(2):174-182.
|
13. |
Bentdal O, FrØland SS, Bosnes V, et al. Alteration in lymphocyte subsets in blood may predict resectibility in carcinoma of cardia or oesophogus. Cancer Letters, 1996, 100(1-2):133-138.
|
14. |
周永昌, 郭万学.超声医学.第4版.北京:北京科学技术文献出版社, 2003:1622-1624.
|
15. |
陈晓明, 罗鹏飞, 邵培坚, 等.肝癌栓塞化疗生存3年以上48例临床分析.中华放射学杂志, 1995, 29(12):876-877.
|
16. |
Lau WY, Lai EC. The current role of radiofrequency ablation in the management of hepatocellular carcinoma:a systematic review. Ann Surg, 2009, 249(1):20-25.
|
17. |
Buscarini L, Rossi S. Technology for radiofrequency thermal ablation of liver tumors. Semin Laparosc Surg, 1997, 4(2):96-101.
|
18. |
Ali MY, Grimm CF, Ritter M, et a1. Activation of dendritic cells by local ablation of hepatocellular carcinoma. J Hepatol, 2005, 43(5):817-822.
|
19. |
郭颖, 乔正荣.射频消融治疗恶性肿瘤现状.中华肿瘤防治杂志, 2006, 13(9):703-706.
|
20. |
梁萍, 董宝玮, 于小玲, 等.超声引导下经皮微波凝固治疗肝癌的临床应用.中华肿瘤杂志, 1997, 19(6):448-450.
|
21. |
刘君, 蒲永东, 范志忠, 等.西米替丁对大肠癌根治术后患者的免疫调节作用及临床意义.中华普通外科杂志, 2002, 17(2):72-74.
|
22. |
Seki S, Habu Y, Kawamura T, et al. The liver as a crucial organ in the first line of host defense:the roles of Kupffer cells, natural killer (NK) cells and NK1.1 Ag+ T cells in T helper 1 immune responses. Immunol Rev, 2000, 174:35-46.
|
23. |
Smyth MJ, Thia KY, Street SE, et al. Defferential tumor surveillance by NK and NKT cells. J Exp Med, 2000, 191(4):661-668.
|